These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29467523)

  • 1. Early low-dose hydrocortisone: is the neurodevelopment affected?
    Ofman G; Perez M; Farrow KN
    J Perinatol; 2018 Jun; 38(6):636-638. PubMed ID: 29467523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
    Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
    JAMA; 2017 Apr; 317(13):1329-1337. PubMed ID: 28384828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
    Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
    Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.
    Watterberg KL; Walsh MC; Li L; Chawla S; D'Angio CT; Goldberg RN; Hintz SR; Laughon MM; Yoder BA; Kennedy KA; McDavid GE; Backstrom-Lacy C; Das A; Crawford MM; Keszler M; Sokol GM; Poindexter BB; Ambalavanan N; Hibbs AM; Truog WE; Schmidt B; Wyckoff MH; Khan AM; Garg M; Chess PR; Reynolds AM; Moallem M; Bell EF; Meyer LR; Patel RM; Van Meurs KP; Cotten CM; McGowan EC; Hines AC; Merhar S; Peralta-Carcelen M; Wilson-Costello DE; Kilbride HW; DeMauro SB; Heyne RJ; Mosquera RA; Natarajan G; Purdy IB; Lowe JR; Maitre NL; Harmon HM; Hogden LA; Adams-Chapman I; Winter S; Malcolm WF; Higgins RD;
    N Engl J Med; 2022 Mar; 386(12):1121-1131. PubMed ID: 35320643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year neurodevelopmental outcomes of extremely preterm infants treated with early hydrocortisone: treatment effect according to gestational age at birth.
    Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
    Arch Dis Child Fetal Neonatal Ed; 2019 Jan; 104(1):F30-F35. PubMed ID: 29321180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial.
    Onland W; Offringa M; Cools F; De Jaegere AP; Rademaker K; Blom H; Cavatorta E; Debeer A; Dijk PH; van Heijst AF; Kramer BW; Kroon AA; Mohns T; van Straaten HL; te Pas AB; Theyskens C; van Weissenbruch MM; van Kaam AH
    BMC Pediatr; 2011 Nov; 11():102. PubMed ID: 22070744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial.
    He Y; Zhang Y; Gao S; Wang X; He N; Zhang D; Dong W; Wieg C; Lei X
    Trials; 2020 Sep; 21(1):762. PubMed ID: 32883333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants.
    Watterberg KL; Shaffer ML; Mishefske MJ; Leach CL; Mammel MC; Couser RJ; Abbasi S; Cole CH; Aucott SW; Thilo EH; Rozycki HJ; Lacy CB
    Pediatrics; 2007 Jul; 120(1):40-8. PubMed ID: 17606560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental Findings and Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants.
    Héneau A; Guimiot F; Mohamed D; Rideau Batista Novais A; Alberti C; Baud O;
    Pediatrics; 2018 Feb; 141(2):. PubMed ID: 29348196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic hydrocortisone in extremely preterm infants and brain MRI abnormality.
    Alison M; Tilea B; Toumazi A; Biran V; Mohamed D; Alberti C; Bourmaud A; Baud O;
    Arch Dis Child Fetal Neonatal Ed; 2020 Sep; 105(5):520-525. PubMed ID: 31980445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive outcomes at age 5 years after prophylactic hydrocortisone in infants born extremely preterm.
    Trousson C; Toumazi A; Bourmaud A; Biran V; Baud O
    Dev Med Child Neurol; 2023 Jul; 65(7):926-932. PubMed ID: 36417367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.
    Juul SE; Comstock BA; Wadhawan R; Mayock DE; Courtney SE; Robinson T; Ahmad KA; Bendel-Stenzel E; Baserga M; LaGamma EF; Downey LC; Rao R; Fahim N; Lampland A; Frantz ID; Khan JY; Weiss M; Gilmore MM; Ohls RK; Srinivasan N; Perez JE; McKay V; Vu PT; Lowe J; Kuban K; O'Shea TM; Hartman AL; Heagerty PJ;
    N Engl J Med; 2020 Jan; 382(3):233-243. PubMed ID: 31940698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan.
    Onland W; Merkus MP; Nuytemans DH; Jansen-van der Weide MC; Holman R; van Kaam AH;
    Trials; 2018 Mar; 19(1):178. PubMed ID: 29523175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of systemic hydrocortisone in ventilated preterm infants on parent-reported behavioural outcomes at 2 years' corrected age: follow-up of a randomised clinical trial.
    Halbmeijer NM; Onland W; Cools F; Swarte RM; van der Heide-Jalving M; Dijk P; Mulder-de Tollenaer S; Tan RNGB; Mohns T; Bruneel E; van Heijst AFJ; Kramer B; Debeer A; van Weissenbruch MM; Marechal Y; Blom H; Plaskie K; Offringa M; van Wassenaer-Leemhuis AG; van Kaam AH; Aarnoudse-Moens CSH;
    Arch Dis Child Fetal Neonatal Ed; 2023 Jul; 108(4):373-379. PubMed ID: 36593110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying effect modifiers of systemic hydrocortisone treatment initiated 7-14 days after birth in ventilated very preterm infants on long-term outcome: secondary analysis of a randomised controlled trial.
    Halbmeijer NM; Sonnaert M; Swarte RM; Koopman-Esseboom C; van Stuijvenberg M; Mulder-de Tollenaer S; Tan RNGB; Mohns T; Bruneel E; Steiner K; Kramer BW; Debeer A; van Weissenbruch MM; Marechal Y; Blom H; Plaskie K; Offringa M; Merkus MP; Onland W; Leemhuis AG; van Kaam AH;
    Arch Dis Child Fetal Neonatal Ed; 2024 Feb; 109(2):159-165. PubMed ID: 37722765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.